On May 13, Mr. Li Jun, Secretary of the Party Committee and Chairman of Shandong Pharmaceutical Association, led a delegation to Qidu Pharma for inspection and conducted discussions on the theme "Integrated Development of Medical, Commercial, and Industrial Sectors Under New Circumstances."

Chairman Li delivered remarks during the symposium, while Mr. Zhao Fangjun (Director of the Association's Drug Circulation and Supply Committee) and Mr. Ma Yuming (Committee Secretary-General) presented relevant insights. The meeting was chaired by Mr. Zheng Jiaqing, Vice Chairman of the Pharmaceutical Chemistry Committee of Shandong Pharmaceutical Association and Chairman of Qidu Pharma. Attendees included General Manager Zhang Jianyong and Senior Deputy General Manager Cui Liangfeng.

Mr. Zheng extended a warm welcome to the delegation, providing an overview of Qidu Pharma’s historical development, industrial layout, product portfolio, economic performance, brand building, and leadership development. He acknowledged the Association's pivotal role in facilitating academic guidance and industry-academia collaboration, particularly in commercializing scientific achievements and providing technical consultations that support enterprise growth. Emphasizing the irreplaceable role of pharmaceutical circulation and supply in ensuring medication accessibility and industry advancement, Mr. Zheng stated: "Our company will actively explore new collaborative models in drug circulation and establish community of shared future relationships with hospitals, distributors, and pharmaceutical enterprises." He further shared perspectives on current industry trends and corporate operations.

The delegation toured Qidu Pharma's large-scale injection production workshop (annual capacity: 1 billion bottles/bags) and intelligent warehousing logistics system. Chairman Li commended Qidu Pharma's developmental achievements through its "Five Persistences and Two Building Initiatives," which have enabled "dual leaps" in growth. He congratulated Chairman Zheng on being honored as a National Model Worker, noting: "This recognition celebrates not only Mr. Zheng's personal contributions but also industry-wide acknowledgment of Qidu Pharma's brand excellence, product quality, and developmental accomplishments—bringing pride to Shandong's pharmaceutical sector." Chairman Li highlighted Qidu Pharma's role as an industry benchmark in implementing the "Industrial-Commercial Community of Shared Future" concept, praising its significant contributions to:

Advancing intelligent pharmaceutical manufacturing.

Enhancing drug quality standards.

Strengthening industry-academia-research collaboration.

Integrating circulation and supply chain systems.

He urged Qidu Pharma to continue supporting the Association's initiatives, leverage its exemplary leadership, and pioneer new pathways for coordinated "production-supply-warehousing-sales" development. Chairman Li concluded: "We look forward to collaborating with Qidu Pharma and Association members to tackle industry challenges and achieve breakthroughs for Shandong's pharmaceutical sector in the new development paradigm."